Bipolar Disorder: Clinical Trials

11 trials for Bipolar Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 withdrawn. 11 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Withdrawn 11
Phase 12Withdrawn 2
Phase 31Withdrawn 1

Follow Bipolar Disorder: new trials by email Literature Review of Bipolar Disorder trials Research Report on Bipolar Disorder

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder
Inositol - Bipolar Disorder, Anxiety Disorders
Phase 1 / Phase 2WithdrawnRonald M. Glick, MD2023-08-012023-10-06
Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
Lithium, Placebo, Ketamine - Treatment Resistant Depression
Phase 2WithdrawnWilliam V. Bobo, M.D.2017-11-302018-08-16
Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression
Valproate and Placebo, Valproate and Cytidine-containing Drug, Valproate and Creatine-containing Drug - Depression, Bipolar
Phase 2WithdrawnEwha Womans University Mokdong Hospital2016-03-012018-02-09
Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression
Valproate+Cytidine-+Creatine-, Valproate+Cytidine-, Valproate - Bipolar Depression
Phase 2WithdrawnEwha Womans University2015-12-012018-02-09
Trial of Ketamine and Lithium Therapy in Bipolar Depression
Placebo, Ketamine, Ketamine/Lithium - Bipolar Depression
Phase 2WithdrawnYale University2013-01-012023-03-01
Deep Brain Stimulation (DBS) for Treatment Resistant Bipolar Disorder
DBS Activa PC systems Medtronic, DBS, Activa PC systems Medtronic - Bipolar Disorder
Phase 2 / Phase 3WithdrawnUniversity Hospital, Bonn2010-05-012018-08-07
A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder
Ceftriaxone - Bipolar Disorder
Phase 2WithdrawnNational Institute of Mental Health (NIMH)2007-08-012017-07-02
Transcranial Magnetic Stimulation for Bipolar Depression
Transcranial Magnetic Stimulation - Bipolar Depression
Phase 1 / Phase 2WithdrawnThe University of New South Wales2007-04-012023-04-03
rTMS for Treatment of Depressed Phase of Bipolar Disorder Type II
Repetitive Transcranial Magnetic Stimulation (rTMS) - Bipolar Disorder
Phase 2WithdrawnUniversity of Texas Southwestern Medical Center2007-02-012016-06-09
RU-486 in the Treatment of Bipolar Depression
mifepristone (RU-486), Placebo - Bipolar Depression
Phase 2WithdrawnUniversity of British Columbia2006-07-012014-01-22
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
Coenzyme Q10 - Bipolar Affective Disorder, Depression
Phase 2WithdrawnNational Institute of Mental Health (NIMH)2006-05-012011-11-23

Narrower conditions

Depression (4)  ·  Anxiety Disorders (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Mood Disorders (1)

Broader conditions

Bipolar and Related Disorders (11)  ·  Mental Disorders (11)  ·  Mood Disorders (10)  ·  Behavior (4)  ·  Behavioral Symptoms (4)  ·  Depressive Disorder (1)

Interventions

Ketamine (2)  ·  Lithium (2)  ·  Transcranial Magnetic Stimulation (2)  ·  Valproic Acid (2)  ·  Ceftriaxone (1)  ·  Creatine (1)  ·  Cytidine (1)  ·  Deep Brain Stimulation (1)  ·  Inositol (1)  ·  Lithium Carbonate (1)  ·  Mifepristone (1)  ·  coenzyme Q10 (1)

Sponsors

National Institute of Mental Health (NIMH) (2)  ·  Ewha Womans University (1)  ·  Ewha Womans University Mokdong Hospital (1)  ·  Ronald M. Glick, MD (1)  ·  The University of New South Wales (1)  ·  University Hospital, Bonn (1)  ·  University of British Columbia (1)  ·  University of Texas Southwestern Medical Center (1)  ·  William V. Bobo, M.D. (1)  ·  Yale University (1)

Countries

United States (5)  ·  South Korea (2)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)

Top investigators

Allan Young, MD (1)  ·  Chadi Abdallah, MD (1)  ·  Colleen Loo, FRANZCP, MD (1)  ·  F. Andrew Kozel, MD, MSCR (1)  ·  In Kyoon Lyoo, MD, PhD, MMS (1)  ·  Ronald Glick, MD (1)  ·  William Lyndon, FRANZCP (1)  ·  William V Bobo (1)

NIH funding

T32DA022975 (1)